ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Aethlon Medical, Inc. (AEMD) stock surged +1.60%, trading at $0.36 on NASDAQ, up from the previous close of $0.35. The stock opened at $0.35, fluctuating between $0.35 and $0.36 in the recent session.
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Employees | 14 |
Beta | 1.81 |
Sales or Revenue | $0.00 |
5Y Sales Change% | -0.847% |
Fiscal Year Ends | March |
Sector | Healthcare |
Industry | Medical - Devices |